The soon-to-issue patent contains composition of matter and methods of use claims for a family of novel prodrug derivatives of psilocybin. The post Enveric...
Clinical psychologist and professor Monnica Williams is on a mission to bring psychedelics to therapists’ offices to help people heal from their racial...
Can psychedelics assist in recovery from eating disorders? The findings are promising, but patients and doctors need to proceed with caution until there...
What does it look like, where does it come from, and how strong is it? All this and more in our latest guide on Psilocybe Natalensis...
For those interested in ketamine treatment, there is a vast array of potential therapies designed to meet you where you’re at.
Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing...
Neuroscience research shows that the brain changes slowly through effortful learning, but can also rapidly rewire during transformative experiences, like...
The company said it has enough cash to continue operations into 2026. The post MindMed Advances Medical LSD Studies for Anxiety, Autism with $177M in the...
–Company to host conference call to discuss positive Phase 2 CYB003 interim results today, November 1, 2023 at 11:00 a.m. ET – – Complete Phase 2...
This morning we received interim results on Cybin’s Phase 2 trial using its CYB003 psilocybin compound for depression. And they did not disappoint. The...